Upstream Bio
Price & Volume
Stats
See more52W Range | $7.25-$33.68 |
Market Cap | $446.7M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $3.3M |
Revenue Growth (YoY) | 82.7% |
Gross Profit (12 Mos) | $3.3M |
Diluted EPS | -$2.90 |
News
See moreYahoo Finance • 15 days ago
Upstream Bio, Inc. reports Q1 results
Yahoo Finance • last month
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Yahoo Finance • 2 months ago
Wix downgraded, TripAdvisor upgraded: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch
About
CEO | Dr. E. Rand Sutherland M.D., M.P.H. |
CFO | Mr. Michael Paul Gray CPA, MBA |
Address | 890 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 75 |